+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Requip"

CNS Therapeutics - Global Strategic Business Report - Product Thumbnail Image

CNS Therapeutics - Global Strategic Business Report

  • Report
  • February 2026
  • 506 Pages
  • Global
From
From
Restless Legs Syndrome Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Restless Legs Syndrome Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
From
From
  • 7 Results (Page 1 of 1)
Loading Indicator

Requip (ropinirole) is a dopamine agonist used to treat symptoms of Parkinson's disease and restless legs syndrome. It is a member of the non-ergoline dopamine agonist class of drugs, which are used to treat Parkinson's disease and other movement disorders. Requip is also used to treat symptoms of depression and anxiety. It works by increasing the amount of dopamine in the brain, which helps to improve movement and reduce symptoms of Parkinson's disease. Requip is a popular drug in the Central Nervous System (CNS) drug market. It is used to treat a variety of neurological conditions, including Parkinson's disease, restless legs syndrome, and depression. It is also used to treat symptoms of anxiety. Requip is generally well-tolerated and has few side effects. The CNS drug market is a large and growing market, with many different drugs available to treat a variety of neurological conditions. Requip is one of the most popular drugs in this market, due to its effectiveness and safety profile. Some companies in the Requip market include GlaxoSmithKline, Pfizer, and Novartis. Show Less Read more